Cargando…

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer

Radiotherapy is used to treat many different human tumors. Paradoxically, radiation can activate TGF-β1 signaling and induce the epithelial-mesenchymal transition (EMT), which is associated with enhanced tumor progression. This study investigated the inhibitory effects of halofuginone, a plant-deriv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yang, Liu, Weishuai, Wang, Peng, Hou, Hailing, Liu, Ningbo, Gong, Linlin, Wang, Youyou, Ji, Kai, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342082/ https://www.ncbi.nlm.nih.gov/pubmed/27533085 http://dx.doi.org/10.18632/oncotarget.11217

Ejemplares similares

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2018)

Inhibition of TGF-β signaling with halofuginone can enhance the antitumor effect of irradiation in Lewis lung cancer
por: Lin, Runlong, et al.
Publicado: (2015)

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Halofuginone — The Multifaceted Molecule
por: Pines, Mark, et al.
Publicado: (2015)

Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma
por: CHEN, WEIGUO, et al.
Publicado: (2013)

Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
por: Keller, Tracy L., et al.
Publicado: (2012)

EtcPRS(Mut) as a molecular marker of halofuginone resistance in Eimeria tenella and Toxoplasma gondii
por: Sun, Pei, et al.
Publicado: (2023)

Transcriptome profile of halofuginone resistant and sensitive strains of Eimeria tenella
por: Sun, Pei, et al.
Publicado: (2023)

Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells
por: Kamberov, Yana G, et al.
Publicado: (2011)

EGFR tyrosine kinase inhibitor HS-10182 increases radiation sensitivity in non-small cell lung cancers with EGFR T790M mutation
por: Chen, Yang, et al.
Publicado: (2018)

Preventive Effect of Halofuginone on Concanavalin A-Induced Liver Fibrosis
por: Liang, Jie, et al.
Publicado: (2013)

Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

Halofuginone functions as a therapeutic drug for chronic periodontitis in a mouse model
por: Wang, Jiang, et al.
Publicado: (2020)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition
por: Wang, Jun, et al.
Publicado: (2017)

Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells
por: Gong, Rui-Hong, et al.
Publicado: (2022)

Cortactin in Epithelial–Mesenchymal Transition
por: Ji, Rong, et al.
Publicado: (2020)

C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
por: Ji, Huanhuan, et al.
Publicado: (2020)

A Novel Synthesis of the Efficient Anti-Coccidial Drug Halofuginone Hydrobromide
por: Zhang, Junren, et al.
Publicado: (2017)

Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition
por: Liu, Qiqi, et al.
Publicado: (2021)

Halofuginone inhibits tumor migration and invasion by affecting cancer-associated fibroblasts in oral squamous cell carcinoma
por: Wang, Danni, et al.
Publicado: (2022)

Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer
por: Chen, Guo-Qing, et al.
Publicado: (2017)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Deng, Yan-Ru, et al.
Publicado: (2016)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

Correction: Norcantharidin Inhibits Renal Interstitial Fibrosis by Blocking the Tubular Epithelial-Mesenchymal Transition
por: Li, Ying, et al.
Publicado: (2013)

The lnc‐CITED2‐2:1 inhibits metastasis via inhibiting CITED2 and epithelial‐mesenchymal transition in gallbladder cancer
por: Shen, Sheng, et al.
Publicado: (2020)

Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone
por: Cui, Zhuang, et al.
Publicado: (2016)

Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
por: Zhang, Juyong, et al.
Publicado: (2013)

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
por: Liu, Zhiyan, et al.
Publicado: (2018)

Polarity and epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy
por: Zou, Hui, et al.
Publicado: (2020)

Expression of CCR6 in esophageal squamous cell carcinoma and its effects on epithelial-to-mesenchymal transition
por: Liu, Jian, et al.
Publicado: (2017)

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)

The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves
por: Naciri, Muriel, et al.
Publicado: (1993)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
por: van der Horst, Paul H., et al.
Publicado: (2012)

Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism
por: Chen, Guo-Qing, et al.
Publicado: (2015)

Ursolic acid inhibits epithelial-mesenchymal transition in vitro and in vivo
por: Xu, Chang-Geng, et al.
Publicado: (2019)

Triptolide inhibits epithelial-mesenchymal transition and induces apoptosis in gefitinib-resistant lung cancer cells
por: Li, Fangqiong, et al.
Publicado: (2020)

SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression
por: Zhang, Hangyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s8s0k7sfrlhjmk9pr1bhj8hqmp